Pure Global
NCT02392754

Home-Based Screening for Early Detection of Atrial Fibrillation in Primary Care Patients Aged 75 Years and Older

Program for Identification of Actionable Atrial Fibrillation (PIAAF): Home-Based Screening for Early Detection of Atrial Fibrillation in Primary Care Patients Aged 75 Years and Older: the SCREEN-AF Randomized Trial
Population Health Research Institute·ClinicalTrials.gov·device·Device trialCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Atrial Fibrillation,Hypertension
Drug/Device/Intervention
Screening: Intervention - Atrial fibrillation screening (ZIO XT ECG monitor, Watch-BP)
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Population Health Research Institute
Location
Calgary,Camrose,Edmonton,Olds,Ayr,Burlington,Etobicoke,Georgetown,Haileybury,Hamilton,Kingston,Markham,Morrisburg,Newmarket,Oakville,Owen Sound,St. Catharines,St. Catherines,Stouffville,Thunder Bay,To, Canada,Germany
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2015
End date
Jan 21, 2020
Enrollment
856 participants
Primary outcome

Detection of new atrial fibrillation or flutter

Summary

Atrial fibrillation (AF) is a major treatable risk factor for stroke, but it may be hard to
 detect because it is frequently silent and intermittent. New ambulatory cardiac monitoring
 technologies have the potential to improve early detection of AF. This trial investigates AF
 screening in primary care patients using the ZIO XT Patch, a wearable adhesive patch monitor
 that provides continuous ECG recording for up to 14 days, in addition to the WatchBP home
 blood pressure monitor that has built-in AF screening capability.

ICD-10 classifications
Chronic atrial fibrillationPersistent atrial fibrillationParoxysmal atrial fibrillationAtrial fibrillation and flutterAtrial fibrillation and atrial flutter, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT02392754
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT02392754 through Pure Global AI's free database. This phase not specified trial is sponsored by Population Health Research Institute and is currently Completed. The study focuses on Atrial Fibrillation,Hypertension. Target enrollment is 856 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.